References
- Birkenhäger W. H., Schalekamp M. A.D.H. Control Mechanisms in Essential Hypertension. Elsevier Scientific Publishing Company, Amsterdam 1976; 135–158; 43–62
- Brechner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand. J. clin. Lab. Incest. 1972; 30: 271
- Davey M. J., Massingham R. A review of the biological effects of prazosin, including recent pharmacological findings. Curr. med. Res. Opin. 1976; 4: 47, Suppl. 2
- Dustan H. P., Tarazi R. C., Bravo E. L. Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N. Engl. J. Med. 1972; 286: 861
- Finnerty F. A., Davidov M., Mroczek W. J., Gavrilovich L. Influence of extracellular fluid volume on response to antihypertensive drugs. Circulat. Res. 1970; 26–27, Suppl. I
- Gilmore E., Weil J., Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N. Engl. J. Med. 1970; 282: 521
- Gottlieb T. B., Katz F. H., Chidsey C. A. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. Circulation 1972; 45: 571
- Gussin R. Z., Stokey E. H., Ronsberg M. A., Malone L. C., Cummings J. R. The effect of guancydine on fluid and electrolyte excretion: a comparison with hydralazine and reserpine. Arch. int. Pharmacodyn. 1971; 192: 135
- Ibsen H., Leth A. Plasma volume and extracellular fluid volume in essential hypertension. Acta med. scand. 1973; 194: 93
- Ibsen H., Rasmussen K., Jensen H. Ârenlund. Changes in plasma volume, extracellular fluid volume and glomerular filtration rate during combined treatment with propranolol and prazosin in hypertensive patients. Curr. med. Res. Opin. 1976; 4: 83, Suppl. 2
- Ibsen H., Rasmussen K., Jensen H., Ârenlund Leth A. Changes in plasma volume and extracellular fluid volume after addition of hydralazine to propranolol treatment in patients with hypertension. Acta med. scand. 1978; 203: 419
- Ibsen H., Sederberg-OIsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin. Sci. 1973; 44: 129
- Kincaid-Smith P. Vasodilators in the treatment of hypertension. Med. J. Aust. 1975; 7, Special Suppl. 1
- Koshy M. C., Mickley D., Bourgoignie J., Blaufox M. D. Physiologic evaluation of a new antihypertensive agent: prazosin HC1. Circulation 1977; 55: 533
- Leth A. Body fluid compartments in essential hypertension. Thesis, Copenhagen 1976
- Lund-Johansen P. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension. Postgrad. Med. 1975; 45, Special Issue
- Marshall A. J., Pocock J., Barritt D. W., Heaton S. T. Evaluation of beta blockade, bendrofluazide, and prazosin in severe hypertension. Lancet 1977; i: 271
- Maxwell M. H. Effects of prazosin on renal function and fluid-electrolyte metabolism. Postgrad. Med. 1975; 36, Special Issue
- Rasmussen K., Jensen H. Â. A cross-over study between hydralazine and prazosin. Clin. Sci. molec. Med. 1976; 51: 621s
- Rønnov-Jessen V., Hansen J. Blood volume and exchangeable sodium during treatment with guanethidine and hydrochlorothiazide. Acta med. scand. 1969; 186: 255
- Schirger A., Sheps S. G. Prazosin new hypertensive agent. A double-blind crossover study in the treatment of hypertension. J. Amer. med. Ass. 1977; 237: 989
- Sederberg-O Isen P., Ibsen H. Plasma volume and extracellular fluid volume during long-term treatment with propranolol in essential hypertension. Clin. Sci. 1972; 43: 165
- Smith I. S., Fernandes M., Kim K. E., Swartz C., Onesti G. A three-phase clinical evaluation of prazosin. Postgrad. Med. 1975; 53, Special Issue
- Stokes G. S., Weber M. A. Prazosin: Preliminary report and comparative studies with other antihypertensive agents. Brit. Med. J. 1974; 2: 298
- Tobian L., Lange J., Magraw S., Coffee K. Body sodium and hypertension, sodium retention by 'hypertensive' kidneys. Trans. Ass. Amer. Phys. 1974; 87: 225
- Verhiest W., Croonenberghs J., Devos P., Fagard R., Amery A. Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension. Acta Cardiol. 1974; 29: 217
- Zacest R. The vasodilator-beta-blocker interaction —some determinants of its clinical success. Aust. N.Z.J. Med. 1976; 6: 65
- Zins G. R. Alterations in renal function during vasodilator therapy. Recent Advances in Renal Physiology and Pharmacology., L. G. Wesson, G. M. Fanelli. University Park Press, Baltimore 1974; 165